Inogen Inc INGN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if INGN is a good fit for your portfolio.
News
-
Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference
-
Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Inogen Announces Fourth Quarter and Full-Year 2023 Financial Results
-
Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
-
Inogen Names Michael Bourque as New Chief Financial Officer
Trading Information
- Previous Close Price
- $7.97
- Day Range
- $7.90–8.19
- 52-Week Range
- $4.13–14.10
- Bid/Ask
- $8.04 / $8.05
- Market Cap
- $188.25 Mil
- Volume/Avg
- 315,844 / 623,472
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.59
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 834
- Website
- https://www.inogen.com
Comparables
Valuation
Metric
|
INGN
|
MMSI
|
SIBN
|
---|---|---|---|
Price/Earnings (Normalized) | — | 25.17 | — |
Price/Book Value | 0.90 | 3.65 | 3.93 |
Price/Sales | 0.59 | 3.52 | 4.53 |
Price/Cash Flow | — | 20.54 | — |
Price/Earnings
INGN
MMSI
SIBN
Financial Strength
Metric
|
INGN
|
MMSI
|
SIBN
|
---|---|---|---|
Quick Ratio | 2.36 | 3.81 | 8.01 |
Current Ratio | 2.86 | 5.45 | 9.01 |
Interest Coverage | — | 8.07 | −13.52 |
Quick Ratio
INGN
MMSI
SIBN
Profitability
Metric
|
INGN
|
MMSI
|
SIBN
|
---|---|---|---|
Return on Assets (Normalized) | −13.15% | 9.43% | −8.97% |
Return on Equity (Normalized) | −18.72% | 14.77% | −12.61% |
Return on Invested Capital (Normalized) | −19.07% | 11.47% | −11.78% |
Return on Assets
INGN
MMSI
SIBN
Medical Devices Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ABT
| Abbott Laboratories | Bfsqfqm | Cgsyvt | $197.2 Bil | |
SYK
| Stryker Corp | Zwbjdnrzr | Yrqz | $136.2 Bil | |
MDT
| Medtronic PLC | Vkhwkffd | Mrmbngr | $115.7 Bil | |
BSX
| Boston Scientific Corp | Tbjpljdq | Xrvnft | $100.7 Bil | |
EW
| Edwards Lifesciences Corp | Rjftcfpgm | Hmrnpj | $57.5 Bil | |
DXCM
| DexCom Inc | Zfmffnhsp | Rvfl | $53.5 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Zqcbmhdtd | Ykdv | $27.1 Bil | |
ALGN
| Align Technology Inc | Bzjqtlnt | Bxwwp | $24.6 Bil | |
PHG
| Koninklijke Philips NV ADR | Jjpznvj | Ljpgst | $18.2 Bil | |
PODD
| Insulet Corp | Bpzxycvxd | Vfwbzn | $12.0 Bil |